Advertisement Cytori sells StemSource Cell Bank to Biohellenika - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cytori sells StemSource Cell Bank to Biohellenika

Cytori Therapeutics has sold its first EU StemSource Cell Bank as part of an agreement with Biohellenika.

Biohellenika, the provider of cord blood stem cell banking services in Greece, will be the exclusive provider of the StemSource Cell Bank cryopreservation services in Greece.

The StemSource Cell Bank is said to be a comprehensive product offering, which allows companies or hospitals to economically process and store their clients’ adipose tissue-derived stem and regenerative cells for potential future use.

George Koliakos, director and executive manager of Biohellenika, said: “As the provider of cord blood cell banking in Greece, we have the experience to immediately and successfully commercialize Cytori’s adipose tissue-based cell banking product.”